Kit, S., Otsuka, H., Qavi, H.B., Hazen, M. Herpes simplex virus thymidine kinase activity of thymidine kinase-deficient Eschericha coli K12 mutant transformed by hybrid plasmids. Proc. Natl. Acad. Sci. USA 78:582-586, 1981.
Qavi, H.B., Green, M.T., SeGall, G.K. and Font, R.L. Demonstration of HIV-1 and HHV-6 in AIDS-associated retinitis. Current Eye Research 8(4):379-387, 1989.
Qavi, H.B., Green, M.T., SeGall, G.K., Hollinger, F.B. and Lewis, D.E. The incidence of HIV-1 and HHV-6 in corneal buttons. Current Eye Research 10(suppl):97-103, 1991.
Qavi, H.B., Green, M.T. and SeGall, G.K. HIV-1 and HHV-6 infections of human retina and cornea. In: human Herpes virus 6: Epidemiology, Molecular Biology, and Clinical Pathology (D.V. Ablashi and G.R.F. Krueger, Eds.) Amsterdam, Elsevier Science Publishers, pp. 263-280, 1992.
Qavi, H.B., Green, M.T., SeGall, G.K., Lewis, D.E. and Hollinger, F.B. Frequency of dual infections of corneas with HIV-1 and HHV-6. Current Eye Research, 11:315-323, 1992.
Qavi, H.B., Green, M.T. and SeGall, G.K. Transcriptional activity of HIV-1 and HHV-6 in retinal lesions from AIDS patients. Inves. Ophth. Vis. Sci. 33(10):2759-2767, 1992.
Qavi HB, Green MT, Lewis DE, Hollinger FB, Pearson G, and Ablashi DV. HIV-1 and HHV-6 antigens and transcripts in retinal cells from AIDS patients in the absence of CMV infection. Inves. Ophth. Vis. Sci. 36(10): 2040-2047, 1995.
O’Brien, WJ; Qavi, HB; Taylor, JL. The Human Herpes viruses, 5,6,7,8. In: Duane’s Foundation of Clinical Ophthalmology. Tasman W and Jaeger EA editors, J.B. Lippincott Company. 93:1-14, 1998.
Qavi HB; and Jaffari AA. Coinfection of Retinal Cells with HCMV and HIV-1 in Vitro. Pathogenesis. 1 (4): 239-244, 2000.
Qavi HB; Adam E; Melnick JL; and DeBakey ME. Frequency of coexistence of Cytomegalovirus and Chlamydia Pneumoniae in Atherosclerotic plaques. Cen. Euro.J.Pub.Health. 8(2): 71-73, 2000.
Qavi HB; Wyde P; and Kahn M. In vitro antiviral activity of sophocarpines against HHV-6. Phytotherapy Research, 16 (2): 154-156, 2002
1Qavi HB; El-Gazeery A. HHV-6 infection of mammalian cells in vitro. Saudi J.Ophthalmology. 16: 3-10, 2002.
Qavi HB; and Ablashi DV. The Human Herpes virus 8 and Kaposi’s sarcoma. In Duane’s Foundation of clinical Ophthalmology. Tasman W and Jaeger Ea. Editors, J.B. Lippincott Company. 93a: 1-10, 2003.
Qavi HB and Al-Rajih AA. Acetylcholinesterase and HHV-8 in Squamous Cell Carcinoma and Retinoblastoma. In Vivo 23: Number 5: 679 - 683, 2009.
Qavi HB and Hessel T. The Efficacy of Antiviral Components from Plant Products against Herpes Simplex Virus Type 1. Annals of Virology and Research 1 : Number 1: 1001- 1005, 2015
Cancer continues to represent the largest cause of mortality in the world and claims over 6 million lives each year. Breast cancer is the most common cancer and the leading cause of death in women between 35 to 54 years of age. Current chemotherapeutic drugs for breast cancer show severe side effects and drug resistance. An extremely promising strategy for cancer prevention today is chemoprevention, which is defined as the use of synthetic or natural agents (alone or in combination) to block the developments of cancer. Plants products used in folk and transitional medicine have been accepted currently as one of the main sources of cancer chemopreventive drug discovery and development. A growing body of research has demonstrated that Saffron and Garlic extracts and their main constituents possess chemoprevention properties against breast cancer. Isolation and characterization of biologically active anticancer agents from these sources have not been reported. Further studies are required to evaluate the safety and efficacy of isolated components from Saffron and Pearl garlic in cancer treatment. Preliminary findings from this Laboratory have indicated that selected components from Saffron and Pearl Garlic have strong anticancer efficacy against breast cancer.